Immunoprotein Diagnostic Testing Market Size & Share, by Product Type (Instruments, Kits & Reagents), Technology (Chemiluminescence Assay, Enzyme-based Immunoassay, Immunofluorescence Assay, Immunoturbidity Assay, Immunoprotein Electrophoresis), Application (Infectious Disease, Endocrine, Toxicology) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5311
  • Published Date: Oct 12, 2023
  • Report Format: PDF, PPT

Companies Dominating the Immunoprotein Diagnostic Testing Landscape

    • Thermofisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Abbott Laboratories
    • Abcam plc
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • DiaSorin S.p.A
    • Enzo Biochem
    • Ortho Clinical Diagnostics
    • KSL Diagnostics Inc.
    • KSL Beutner Laboratories

Browse Key Market Insights with Data Illustration:


In The News

  • In July 2022, KSL Beutner Laboratories launched the first indirect immunofluorescence (IIF) serum blood test to market in the United States, which positively identified laminin 332, an antigen associated with mucosal pemphigoid (MMP), a chronic and debilitating autoimmune disease.
  • In April 2022, KSL Diagnostics, Inc launched the first antibody test that detects an individual's immune response to COVID-19 and assesses the risk of infection if exposed. The COVID-19 Immunity Index can help monitor protection against the COVID-19 virus with a simple blood test.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5311
  • Published Date: Oct 12, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of chronic disease and rise in diagnostic tests are some of the major factors anticipated to drive the growth of the immunoprotein diagnostic testing market.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2024-2036.

The major players in the market are of Bio-Rad Laboratories, Inc, Danaher Corporation, DiaSorin S.p.A, Enzo Biochem, Ortho Clinical Diagnostics, KSL Diagnostics Inc., KSL Beutner Laboratories, and others.

The infectious disease segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in Asia Pacific is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying